Is AYTU research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AYTU. It does not provide personalized investment advice.

AYTU (AYTU BioPharma, Inc. Common Stock) Stock Analysis - Financials

AYTU BioPharma, Inc. Common Stock (AYTU) is a publicly traded Healthcare sector company. As of September 16, 2026, AYTU trades at $1.98 with a market cap of $21.36M and a P/E ratio of -0.92. AYTU moved -0.50% today. Year to date, AYTU is -24.23%; over the trailing twelve months it is -15.81%. Its 52-week range spans $0.95 to $3.07. Rallies surfaces AYTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are AYTU's key financials?

AYTU financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AYTU recently traded at $1.98. Market cap is $21.36M. P/E ratio is -0.92. Revenue is $66.38M.

AYTU Key Metrics

Key financial metrics for AYTU
Metric	Value
Price	$1.98
Market Cap	$21.36M
P/E Ratio	-0.92
EPS	$-2.16
Dividend Yield	0.00%
52-Week High	$3.07
52-Week Low	$0.95
Volume	15.95K
Avg Volume	0
Revenue (TTM)	$66.38M
Net Income	$-13.56M
Gross Margin	69.04%

AYTU Analyst Consensus

AYTU analyst coverage data. Average price target: $0.00.

Common questions about AYTU

What are AYTU's key financials?: AYTU financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AYTU recently traded at $1.98. Market cap is $21.36M. P/E ratio is -0.92. Revenue is $66.38M.
Is AYTU research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AYTU. It does not provide personalized investment advice.